KUMAMOTO University

R

研究実績RESEARCH ACHIEVEMENTS

  1. Fuchida S, Kawamura K, Sunami K, Tsukada N, Fujii S, Ohkawara H, Usuki K, Wake A, Endo S, Ishiyama K, Ueda Y, Nakamura Y, Miyamoto T, Fukuda T, Ichinohe T, Atsuta Y, Takamatsu H.

    Retrospective Analysis of Autologous Stem Cell Transplantation for AL Amyloidosis: A Study from the Multiple Myeloma Working Group of the Japan Society for Hematopoietic Cell Transplantation.

    Transplant Cell Ther 28(2):76-82,2022.  doi: 10.1016/j.jtct.2021.10.021.

    https://pubmed.ncbi.nlm.nih.gov/34774818/

     

  2. Ghosh AK, Kovela S, Sharma A, Shahabi D, Ghosh AK, Hopkins DR, Yadav M, Johnson ME, Agniswamy J, Wang YF, Hattori SI, Higashi-Kuwata N, Aoki M, Amano M, Weber IT, Mitsuya H.

    Design, Synthesis and X-ray Structural Studies of Potent HIV-1 Protease Inhibitors Containing C-4 Substituted Tricyclic Hexahydro-furofuran Derivatives as P2 Ligands.

    ChemMedChem doi: 10.1002/cmdc.202200058,2022.  doi: 10.1002/cmdc.202200058.

    https://pubmed.ncbi.nlm.nih.gov/35170223/

  3. Nosaka K, Kusumoto S, Nakano N, Choi I, Yoshimitsu M, Imaizumi Y, Hidaka M, Sasaki H, Makiyama J, Ohtsuka E, Jo T, Ogata M, Ito A, Yonekura K, Tatetsu H, Kato T, Kawakita T, Suehiro Y, Ishitsuka K, Iida S, Matsutani T, Utsunomiya A, Ueda R, Ishida T.

    Clinical significance of the immunoglobulin G heavy-chain repertoire in peripheral blood mononuclear cells of adult T-cell leukemia-lymphoma patients receiving mogamulizumab.

    Br J Haematol 196(3):629-638,2022. doi: 10.1111/bjh.17895. Epub 2021 Oct 10.

    https://pubmed.ncbi.nlm.nih.gov/34632569/

  4. Tamanoi D, Saruwatari K, Imamura K, Sato R, Jodai T, Hamada S, Tomita Y, Saeki S, Ueno S, Yonemura Y, Ichiyasu H, Sakagami T.

    case of pembrolizumab-related immune thrombocytopenia in a patient with lung adenocarcinoma treated by radiotherapy: potential immune-related adverse event elicited by radiation therapy.

    Internal Med 61(11):1731-1734,2022. doi: 10.2169/internalmedicine.

    https://pubmed.ncbi.nlm.nih.gov/34776479/

     

  5. Higuchi Y, Yasunaga JI, Matsuoka M.

    HTLV-1’s foxy strategy for survival and Transmission.

    Front Virol doi: 10.3389/fviro.2021.792659,2022.

    https://www.frontiersin.org/articles/10.3389/fviro.2021.792659/full

  6. Kawano Y, Hata H, Takashio S, Tsujita K, Ueda M, Matsuoka M.

    Daratumumab, lenalidomide and dexamethasone in newly diagnosed systemic light chain amyloidosis patients associated with multiple myeloma

    Br J Haematol ,2022. doi: 10.1111/bjh.18234. Online ahead of print.

    https://pubmed.ncbi.nlm.nih.gov/35524546/

     

  7. Kogure Y, Kameda T, Koya J, Yoshimitsu M, Nosaka K, Yasunaga JI, Imaizumi Y, Watanabe M, Saito Y, Ito Y, McClure MB, Tabata M, Shingaki S, Yoshifuji K, Chiba K, Okada A, Kakiuchi N, Nannya Y, Kamiunten A, Tahira Y, Akizuki K, Sekine M, Shide K, Hidaka T, Kubuki Y, Kitanaka A, Hidaka M, Nakano N, Utsunomiya A, Sica RA, Acuna-Villaorduna A, Janakiram M, Shah UA, Ramos JC, Shibata T, Takeuchi K, Takaori-Kondo A, Miyazaki Y, Matsuoka M, Ishitsuka K, Shiraishi Y, Miyano S, Ogawa S, Ye BH, Shimoda K, Kataoka K.

    Whole-genome landscape of adult T-cell leukemia/lymphoma.

    Blood 139(7):967-982,2022. doi: 10.1182/blood.2021013568.

    https://pubmed.ncbi.nlm.nih.gov/34695199/

  8. Zhao T, Wang Z, Fang J, Chengc W, Zhang Y, Huang J, Xu L, Zeng L, Jin Z, and Matsuoka M.

    HTLV-1 activates YAP by NF-κB/p65 to promote oncogenesis.

    Proc Natl Acad Sci USA  119(9):e2115316119,2022. doi: 10.1073/pnas.2115316119.

    https://pubmed.ncbi.nlm.nih.gov/35210364/

  9. Masayuki Amano, Ravikiran S Yedidi, Pedro Miguel Salcedo-Gómez, Hironori Hayashi, Kazuya Hasegawa, Cuthbert D Martyr, Arun K Ghosh, Hiroaki Mitsuya.

    Fluorine-Modifications Contribute to Potent Antiviral Activity against Highly Drug-Resistant HIV-1 and Favorable Blood-Brain Barrier (BBB) Penetration Property of Novel Central Nervous System (CNS)-targeting HIV-1 Protease Inhibitors In Vitro.

    Antimicrob Agents Chemother. 2022 Jan 3; AAC0171521. doi: 10.1128/AAC.01715-21.

    https://journals.asm.org/doi/10.1128/AAC.01715-21

    https://pubmed.ncbi.nlm.nih.gov/34978889/

     

     

  10. Rajib S.A, Ogi Y, Hossain M.B, Ikeda T, Tanaka E, Kawaguchi T, Satou Y.

    A SARS-CoV-2 Delta variant containing mutation in the probe binding regions used for RT-qPCR test in Japan exhibited atypical PCR amplification and might induce false negative result.

    J Infect Chemother 28(5):669-677,2022. doi: 10.1016/j.jiac.2022.01.019

    https://pubmed.ncbi.nlm.nih.gov/35144878/

     

  11. Ikezoe T, Noji H, Ueda Y, Kanda Y, Okamoto S, Usuki K, Matsuda T, Akiyama H, Shimono A, Yonemura Y, Kawaguch T, Chiba S, Kanakura Y, Nishimura J, Ninomiya H, Obara N.

    Long-term follow-up of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab:post-marketing surveillance in Japan.

    Int J Hematol 115(4):470-480,2022. doi: 10.1007/s12185-022-03287-y.

    https://pubmed.ncbi.nlm.nih.gov/35146630/

     

  12. Fuchida SI, Kawamura K, Sunami K, Tsukada N, Fujii S, Ohkawara H, Usuki K, Wake A, Endo S, Ishiyama K, Ueda Y, Nakamura Y, Miyamoto T, Fukuda T, Ichinohe T, Atsuta Y, Takamatsu H.

    Amyloidosis: A Study from the Multiple Myeloma Working Group of the Japan Society for Hematopoietic Cell Transplantation.

    Transplant Cell Ther 28(2):76-82,2022. doi: 10.1016/j.jtct.2021.10.021

    https://pubmed.ncbi.nlm.nih.gov/34774818/

     

  13. Sekiguchi N, Rai S, Munakata W, Suzuki K, Handa H, Shibayama H, Endo T, Terui Y, Iwaki N, Fukuhara N, Tatetsu H, Iida S, Ishikawa T, Iguchi D, Izutsu K.

    Two-year outcomes of tirabrutinib monotherapy in Waldenström’s macroglobulinemia.

    Cancer Sci online ahead of print (DOI:10.1111/cas.15344)

    https://pubmed.ncbi.nlm.nih.gov/35332633/

     

  14. Nosaka K, Crawford B, Yi J, Kuan W, Matsumoto T, Takahashi T.

    Systematic review of survival outcomes for relapsed or refractory adult T-cell leukemia-lymphoma.

    Eur J Haematol 108(3):212-222,2022.  doi: 10.1111/ejh.13728.

    https://pubmed.ncbi.nlm.nih.gov/34862665/

     

  15. Onishi C, Nishikori M, Yakushijin K, Kurahashi S, Nakazawa H, Takamatsu Y, Hashimoto Y, Tatetsu H, Nawa Y, Yoshida M, Kobayashi T, Oyake T, Yano S, Oride A, Suzuki R.

    Lymphoma during pregnancy in Japan: a multicenter retrospective cohort study.

    Int J Hematol 115(3):382-390,2022. doi: 10.1007/s12185-021-03281-w.

    https://pubmed.ncbi.nlm.nih.gov/34981434/

     

  16. Shichijo T, Tatetsu H, Nosaka K, Higuchi Y, Kikukawa Y, Inoue Y, Toyoda K, Yasunaga JI, Matsuoka M.

    Predictive impact of soluble interleukin-2 receptor and number of extranodal sites for identification of patients at very high risk of CNS relapse in diffuse large B-cell lymphoma.

    eJHaem 1–9,2022.

    https://onlinelibrary.wiley.com/doi/10.1002/jha2.393

     

  17. Kawano Y, Sasano T, Arima Y, Kushima S, Tsujita K, Matsuoka M, Hata H.

    A novel PDK1 inhibitor, JX06, inhibits glycolysis and induces apoptosis in multiple myeloma cells.

    Biochem Biophys Res Commun 587: 153-159,2022. doi: 10.1016/j.bbrc.2021.11.102.

    https://pubmed.ncbi.nlm.nih.gov/34875534/

     

  18. Inoue Y, Nishimura N, Murai M, Matsumoto M, Watanabe M, Yamada A, Izaki M, Nosaka K, Matsuoka M.

    Prevention of acute graft-versus-host disease in adult T-cell leukemia-lymphoma patients who received mogamulizumab before allogeneic hematopoietic cell transplantation.

    Int J Hematol 115(3):435-9,2022.  doi: 10.1007/s12185-021-03250-3.

    https://pubmed.ncbi.nlm.nih.gov/34705226/

     

CONTACT US

C

  • 患者様へ

    外来診療の方は外来予約センターより
    ご予約をお願いいたします。
    外来予約センター

  • 学生・研修医・医療関係者の方へ

    TEL
    096-373-5156
    FAX
    096-373-5158
    Mail
    nikyo@kumamoto-u.ac.jp
Copyright 2019 KUMAMOTO University HRI All Rights Reserved.